Bio-techne Corp. logo

Bio-techne Corp. (TECH)

$72.98

Bio-techne Corp. (TECH) Share Price Forecast
Currently 19 wall-street analysts regularly analyze the financials of Bio-techne Corp. on a frequent basis to provide recommendations along with target share price. 19 analysts offering 12-month price forecasts for Bio-techne Corp. (TECH) have a share price target of $83.32. This median of share price forecast represents a 14.17% upside from the latest price of $72.98 as on 11.10.24.

Bio-techne Corp. (TECH) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Bio-techne Corp. (TECH) share price will touch around $83.32 in next 12-months.
Bio-techne Corp. (TECH) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Bio-techne Corp.'s share price and its median forecast price. As on 11.10.24, the difference is -6.18%

Bio-techne Corp. (TECH): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Bio-techne Corp. (TECH) Share Price : Analyst Recommendation
Based on 19 analysts tracking and researching Bio-techne Corp. (TECH) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
8
9
8
Outperform
9
8
8
Hold
2
3
3
Underperform
0
0
0
Sell
0
0
0
Bio-techne Corp. (TECH) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Bio-techne Corp. (TECH) is $83.32, offered by 19 analysts offering 12-month price forecasts.

Bio-techne Corp. (TECH) has a maximum of 0.14 upside potential, based on 19 analysts offering 12-month price forecasts.

Based on 19 analysts tracking and researching Bio-techne Corp. (TECH), 84.21% have a buy recommendation. Remaining 15.79% have either sell or hold recommendations.

The latest share price of Bio-techne Corp. (TECH) is $72.98 as of 11/10/2024.

16 of total 19 analysts offering stock ratings for Bio-techne Corp. TECH have recommended buy rating.